Popular Articles

Dr. David B. Samadi Introduces New Prostate Cancer Care Center For Robotic Surgery Patients At Mount Sinai Medical Center
The Mount Sinai Medical Center has a new re center for prostate cancer treatment. Led by David B. Samadi, M.D., Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology, the new state-of-the-art facility at 625 Madison Avenue in New York City specializes in pre- and post-surgery care for patients who undergo a robotic prostatectomy at Mount Sinai"s main campus. It also provides expertise in the treatment of other urologic cancers, including bladder and kidney. A multilingual staff offers assistance with patient travel arrangements, accommodations, and translation services when required.
generic viagra online
Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect On Photoreceptors
Neurotech Pharmaceuticals, Inc. announced that the Company"s product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). RP is a slowly developing condition that causes the progressive degeneration of rod & cone photoreceptor cells in the retina that over time diminishes night and peripheral vision and eventually leads to blindness. RP is an orphan-designated indication for which there are currently no approved treatments.
News of the day
The UGR Hill House The First Research Laboratory To Study Risk Conducts When Driving Motorcycles
The University of Granada will house the first European research centre on teenagers" mental mechanisms when driving motorcycles and carrying out risk conducts, which could be helpful, in a near future, to modify and avoid them. The Faculty of Psychology will house three state-of-the-art simulators there was already one at the UGR so far- that will be useful to do research into these mechanisms, thanks to an agreement signed with the company Honda Motor Co. (Europe); the University will become one of the most important centres around the world in this subject.
Mental Health

Frankenman International Ltd Secures FDA Clearance For Its Entire CHEX Range Of Surgical Staplers

Frankenman International Ltd, the manufacturer and supplier of surgical instruments, announced that its entire CHEX™ range of surgical staplers had been granted FDA approval. This development complements the CE and ISO accreditation it has already acquired. FDA approval endorses Frankenman"s commitment to total quality in surgical stapling and wound closure devices, and further validates its position as a trusted alternative supplier in these markets. Having established itself in Europe and many other international markets, Frankenman International Ltd now plans to expand marketing of the CHEX range into Japan, Australia and Korea by the end of 2009. This will enable more patients and hospitals around the world to benefit from its cost-effective range of surgical instruments. "We are delighted to have secured FDA registration as this globally recognised quality mark will further strengthen surgeons" confidence in our CHEX range of surgical staplers and establish Frankenman International as a credible player," comments Lee Edwards, President of International Business at Frankenman International Ltd. "With a well established, professional and successful distribution network in place, we are now concentrating on strategic growth by accelerating our internal and external R & D programmes so that we can bring even more innovative instruments to our customers in the coming years." Frankenman International Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):